Levodopa
Identifieur interne : 004405 ( Main/Exploration ); précédent : 004404; suivant : 004406Levodopa
Auteurs :Source :
- Movement Disorders [ 0885-3185 ] ; 2002-07.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antiparkinson Agents.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug effects : Psychomotor Performance.
- drug therapy : Parkinson Disease.
- prevention & control : Psychomotor Disorders.
- Humans, Randomized Controlled Trials as Topic.
Url:
DOI: 10.1002/mds.5558
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D15
- to stream Istex, to step Curation: 001D15
- to stream Istex, to step Checkpoint: 002C96
- to stream PubMed, to step Corpus: 003987
- to stream PubMed, to step Curation: 003987
- to stream PubMed, to step Checkpoint: 003A37
- to stream Ncbi, to step Merge: 000864
- to stream Ncbi, to step Curation: 000864
- to stream Ncbi, to step Checkpoint: 000864
- to stream Main, to step Merge: 006410
- to stream Main, to step Curation: 004405
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Levodopa</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:93BB732CFF489F498878058978908B95DFD4E343</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.5558</idno>
<idno type="url">https://api.istex.fr/document/93BB732CFF489F498878058978908B95DFD4E343/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D15</idno>
<idno type="wicri:Area/Istex/Curation">001D15</idno>
<idno type="wicri:Area/Istex/Checkpoint">002C96</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12211137</idno>
<idno type="wicri:Area/PubMed/Corpus">003987</idno>
<idno type="wicri:Area/PubMed/Curation">003987</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003A37</idno>
<idno type="wicri:Area/Ncbi/Merge">000864</idno>
<idno type="wicri:Area/Ncbi/Curation">000864</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000864</idno>
<idno type="wicri:Area/Main/Merge">006410</idno>
<idno type="wicri:Area/Main/Curation">004405</idno>
<idno type="wicri:Area/Main/Exploration">004405</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Levodopa</title>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-07">2002-07</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">S4</biblScope>
<biblScope unit="supplement">4</biblScope>
<biblScope unit="page" from="S23">S23</biblScope>
<biblScope unit="page" to="S37">S37</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">93BB732CFF489F498878058978908B95DFD4E343</idno>
<idno type="DOI">10.1002/mds.5558</idno>
<idno type="ArticleID">MDS5558</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Psychomotor Disorders (prevention & control)</term>
<term>Psychomotor Performance (drug effects)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Psychomotor Performance</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Psychomotor Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004405 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004405 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:93BB732CFF489F498878058978908B95DFD4E343 |texte= Levodopa }}
This area was generated with Dilib version V0.6.23. |